![Joe Manchin at AHA's 2024 SAVE Act legislative briefing.](/sites/default/files/2024-08/AT_0824_SaveActBriefing_900x400.jpg)
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.